Coexistencia de anticuerpos anti-histidil-tRNA-sintetasa y anti-partícula de reconocimiento de la señal en un paciente con polimiositis

Satoh, 2017, A comprehensive overview on myositis-specific antibodies: New and old biomarkers in idiopathic inflammatory myopathy, Clinic Rev Allerg Immunol, 52, 1, 10.1007/s12016-015-8510-y Tieu, 2016, Idiopathic inflammatory myositis, Best Practice Res Clin Rheumatol, 30, 149, 10.1016/j.berh.2016.04.007 Colafrancesco, 2015, Inflammatory myopathies and overlap syndromes: Update on histological and serological profile, Best Practice Res Clin Rheumatol, 29, 810, 10.1016/j.berh.2016.02.005 Stone, 2007, Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy, Arthritis Rheum, 56, 3125, 10.1002/art.22865 Basnayake, 2015, Inflammatory myopathy with anti-SRP antibodies: Case series of a South Australian cohort, Clin Rheumatol, 34, 603, 10.1007/s10067-014-2512-7 Takada, 2009, Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies, Mod Rheumatol, 19, 156, 10.3109/s10165-008-0139-8 Hira, 2012, Acute neuromuscular weakness associated with dengue infection, J Neurosci Rural Pract, 3, 36, 10.4103/0976-3147.91928 Sathasivam, 2012, Statin induced myotoxicity, Eur J Intern Med, 23, 317, 10.1016/j.ejim.2012.01.004 Mammen, 2011, Autoantibodies against 3–hydroxy–3–methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy, Arthritis Rheum, 63, 713, 10.1002/art.30156 Rothwell, 2014, Strategies for evaluating idiopathic inflammatory myopathy disease susceptibility genes, Curr Rheumatol Rep, 16, 446, 10.1007/s11926-014-0446-3